R. Matthew Neff, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 5,000 shares at $1.50 ($8K) on 2017-09-08, disclosed to the SEC on 2017-09-08.
Open-market purchase of $8k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| NOTV | SELL | 2025-10-03 | $3K | — | Filing → |
| NOTV | SELL | 2025-09-04 | $3K | — | Filing → |
| NOTV | SELL | 2025-08-04 | $4K | — | Filing → |